SC
IDXX icon

Savant Capital’s Idexx Laboratories IDXX Stock Holding History

Savant Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
1,969
+435
+28% +$244K ﹤0.01% 848
2026
Q1 		$862K Buy
1,534
+620
+68% +$398K ﹤0.01% 678
2025
Q4 		$618K Sell
914
-38
-4% -$25.9K ﹤0.01% 751
2025
Q3 		$608K Buy
952
+178
+23% +$108K ﹤0.01% 727
2025
Q2 		$415K Buy
774
+147
+23% +$70.3K ﹤0.01% 824
2025
Q1 		$263K Buy
627
+40
+7% +$17.4K ﹤0.01% 895
2024
Q4 		$243K Sell
587
-99
-14% -$43.4K ﹤0.01% 1219
2024
Q3 		$347K Buy
686
+202
+42% +$98.1K ﹤0.01% 1032
2024
Q2 		$236K Sell
484
-97
-17% -$48.7K ﹤0.01% 1071
2024
Q1 		$314K Sell
581
-196
-25% -$107K ﹤0.01% 886
2023
Q4 		$431K Buy
777
+168
+28% +$78.9K 0.01% 606
2023
Q3 		$266K Buy
609
+16
+3% +$7.98K ﹤0.01% 684
2023
Q2 		$298K Sell
593
-56
-9% -$26.8K ﹤0.01% 649
2023
Q1 		$325K Buy
649
+9
+1% +$4.31K 0.01% 579
2022
Q4 		$261K Buy
640
+14
+2% +$5.43K 0.01% 502
2022
Q3 		$204K Sell
626
-59
-9% -$21.7K 0.01% 512
2022
Q2 		$240K Buy
685
+294
+75% +$120K 0.01% 477
2022
Q1 		$214K Sell
391
-73
-16% -$38.4K 0.01% 532
2021
Q4 		$306K Sell
464
-38
-8% -$23.9K 0.01% 447
2021
Q3 		$312K Buy
502
+83
+20% +$55.8K 0.01% 412
2021
Q2 		$265K Buy
+419
New +$231K 0.01% 422

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Savant Capital's IDXX Position: Q2 2026 in Review

Savant Capital increased its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, buying an estimated $244K and bringing the position to 1,969 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Savant Capital first reported a position in IDXX in Q2 2021 and has held it in 21 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Savant Capital held 1,969 shares of Idexx Laboratories worth $1.07M as of Q2 2026.
  • Savant Capital bought 435 Idexx Laboratories shares in Q2 2026, an estimated $244K.
  • Idexx Laboratories made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #848 holding.
  • Savant Capital first reported a position in Idexx Laboratories in Q2 2021 and has held it in 21 quarters since.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.